Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.63 |
| ▸ | TSHR | P16473 | 2/20 | 0.63 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.63 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.63 |
| ▸ | MAPT | P10636 | 3/20 | 0.62 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.62 |
| ▸ | PPARG | P37231 | 4/20 | 0.56 |
| ▸ | PPARD | Q03181 | 4/20 | 0.56 |
| ▸ | PPARA | Q07869 | 4/20 | 0.56 |
| ▸ | TERT | O14746 | 3/20 | 0.56 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.56 |
| ▸ | BLM | P54132 | 2/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.56 |
| ▸ | FABP4 | P15090 | 2/20 | 0.56 |
| ▸ | F7 | P08709 | 2/20 | 0.56 |
| ▸ | F3 | P13726 | 2/20 | 0.56 |
| ▸ | GMNN | O75496 | 1/20 | 0.56 |
| ▸ | USP2 | O75604 | 1/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL380888 | 1.00 | LMNA (0.63) | LMNATSHRNFKB1PMP22MAPT | |
| SCHEMBL258956 | 1.00 | LMNA (0.63) | LMNATSHRNFKB1PMP22MAPT | |
| SCHEMBL14798059 | 1.00 | LMNA (0.63) | LMNATSHRNFKB1PMP22MAPT | |
| SCHEMBL15526298 | 1.00 | LMNA (0.63) | LMNATSHRNFKB1PMP22MAPT | |
| SCHEMBL648618 | 1.00 | LMNA (0.63) | LMNATSHRNFKB1PMP22MAPT | |
| SCHEMBL2014792 | 1.00 | LMNA (0.63) | LMNATSHRNFKB1PMP22MAPT | |
| SCHEMBL1603841 | 1.00 | LMNA (0.63) | LMNATSHRNFKB1PMP22MAPT | |
| SCHEMBL1654500 | 1.00 | LMNA (0.63) | LMNATSHRNFKB1PMP22MAPT | |
| SCHEMBL17744969 | 1.00 | LMNA (0.63) | LMNATSHRNFKB1PMP22MAPT | |
| SCHEMBL174463 | 1.00 | LMNA (0.63) | LMNATSHRNFKB1PMP22MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 279 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115594571-A | Preparation method of single-chain alkyl keto acid vesicle | 河南中医药大学（CN） | 2023-01-13 | — | — | CN | claimed |
| CN-114599666-A | Pif1-like helicase and application thereof | 北京齐碳科技有限公司 | 2022-06-07 | — | — | CN | claimed |
| EP-3058088-A2 | MODIFIED ENZYMES | Oxford Nanopore Technologies Limited (GB) | 2016-08-24 | — | — | EP | claimed |
| WO-2015055981-A2 | MODIFIED ENZYMES | OXFORD NANOPORE TECHNOLOGIES LIMITED (GB) | 2015-04-23 | — | — | WO | claimed |
| WO-2012177721-A1 | MICROORGANISMS FOR PRODUCING 6-AMINOCAPROIC ACID | GENOMATICA, INC. (US) | 2012-12-27 | — | — | WO | claimed |
| EP-2427544-A1 | MICROORGANISMS AND METHODS FOR THE BIOSYNTHESIS OF ADIPATE, HEXAMETHYLENEDIAMINE AND 6-AMINOCAPROIC ACID | Genomatica, Inc. (US) | 2012-03-14 | — | — | EP | claimed |
| WO-2010129936-A1 | MICROORGANISMS AND METHODS FOR THE BIOSYNTHESIS OF ADIPATE, HEXAMETHYLENEDIAMINE AND 6-AMINOCAPROIC ACID | GENOMATICA, INC. (US) | 2010-11-11 | — | — | WO | claimed |
| EP-1123324-B1 | PROCESS USING DIALKYLPEROXIDE COMPOUNDS FOR INITIATING A CHEMICAL REACTION | AKZO NOBEL NV (NL) | 2005-11-02 | — | — | EP | claimed |
| EP-0273090-B1 | SOLUTION POLYMERIZATION OF ACRYLIC ACID DERIVED MONOMERS USING TERTIARY ALKYL( C5)-HYDROPEROXIDES | ATOCHEM NORTH AMERICA, INC. (a Pennsylvania corp.) (US) | 1992-03-18 | — | — | EP | claimed |
| JP-61268753-A | — | — | None | — | — | JP | disclosed |
| CN-121673250-B | Polyamino cationic lipids containing carbamate structures, compositions comprising same and uses | 北京悦康科创医药科技股份有限公司 | 2026-05-15 | — | — | CN | disclosed |
| US-12595495-B2 | Methods of producing omega-hydroxylated fatty acid derivatives | GENOMATICA, INC. (US) | 2026-04-07 | — | — | US | disclosed |
| US-20260069697-A1 | METHOD OF TREATING CANCER | INTENSITY THERAPEUTICS INC (US) | 2026-03-12 | — | — | US | disclosed |
| US-12496345-B2 | Method of treating cancer | INTENSITY THERAPEUTICS, INC. (US) | 2025-12-16 | — | — | US | disclosed |
| EP-0232982-A2 | Treatment of skin disorders | UNILEVER PLC (GB) | 1987-08-19 | — | — | EP | disclosed |
| US-4666626-A | OXO-HEXYL ACETATE, CYCLOHEXANONE | C.L.M., INC. (US) | 1987-05-19 | — | — | US | disclosed |
| JP-S61268753-A | POLYESTER PACKAGING MATERIAL | TEIJIN LTD | 1986-11-28 | — | — | JP | disclosed |
| US-4548873-A | GOOD SENSITIVITY, STORAGE STABILITY SOUND QUALITY | FUJI PHOTO FILM CO., LTD. (JP) | 1985-10-22 | — | — | US | disclosed |
| US-4164508-A | USED AS ANTISTATIC AGENTS AND MONOMERS FOR TEXTILES | Snia Viscosa Societa' Nazionale Industria Viscosa S.p.A. (IT) | 1979-08-14 | — | — | US | disclosed |
| US-4085127-A | Method for producing aldehyde acids by selective ozonization of cyclo-olefins | SNIA Viscosa Societa' Nazionale Industria Application Viscosa S.p.A. (IT) | 1978-04-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12595495-B2 | Methods of producing omega-hydroxylated fatty acid derivatives | CYP4F11, CYP2F1, CYP4Z1 | LMNA 3439/4885TSHR 1330/4885NFKB1 2370/4885 |
| US-12496345-B2 | Method of treating cancer | PBK, GZMB, NPC1L1 | LMNA 2389/4885TSHR 2913/4885NFKB1 1820/4885 |
| US-20260069697-A1 | METHOD OF TREATING CANCER | PBK, GZMB, KLRK1 | LMNA 1524/4885TSHR 1039/4885NFKB1 2275/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.